In this study, we applied information obtained from publicly-available protein and gene expression datasets to gain further insight into our overarching research question: does SHP-2 activity or expression influence PD-L1 mRNA and protein levels and subsequent response to anti-PD-1 or PD-L1 therapies in NSCLC? Here, PDCD1 is linked to non-small cell lung carcinoma.